
Novel Foxo1 ингибитор, exerting anti-diabetic and anti-hypertriglyceridemic effects by improving blood glucose and triglyceride metabolism at the gene expression level
Novel Foxo1 inhibitor, exerting anti-diabetic and anti-hypertriglyceridemic effects by improving blood glucose and triglyceride metabolism at the gene expression level
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.